<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Architectural Antigen-Flow Mismatch Theory (AAFMT) - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-54</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-54</p>
                <p><strong>Name:</strong> Architectural Antigen-Flow Mismatch Theory (AAFMT)</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of why patients with thymomas have high rates of autoimmunity, based on the following results.</p>
                <p><strong>Description:</strong> Thymomas produce autoimmunity because they decouple three normally aligned processes required for central tolerance: (1) generation/positioning of thymocytes, (2) delivery/display of diverse self-antigen peptides (AIRE/Fezf2-driven TRAs plus autophagy/protease-generated peptides), and (3) directed trafficking of thymocytes to medullary APC networks (chemokine-guided migration). In thymoma, residual thymopoiesis persists (immature thymocytes are abundant), but medullary antigen-flow and/or migration cues are distorted, creating ‘antigen shadow’ gaps—self-antigen classes that are underrepresented in the selection synapse. The result is selective escape of autoreactive T cells to particular antigen categories (e.g., neuromuscular junction/muscle, skin adhesion molecules), explaining why certain organ-specific syndromes (MG, PNP/pemphigus variants, PRCA) are enriched and why histotype (thymopoietic AB/B types) matters.</p>
                <p><strong>Knowledge Cutoff Year:</strong> 2029</p>
                <p><strong>Knowledge Cutoff Month:</strong> 12</p>
                <p><strong>Base Model:</strong> openai/gpt-5.2-2025-12-11</p>
            </div>
        </div>
        </div>

        <div class="section">
            <h2>Theory (Statement/Laws)</h2>

            <h3>Theory Statements/Laws</h3>
            <hr/>
            <h3>Statement 0: Antigen-shadow gap law (TRA + peptide-supply + migration alignment)</h3>
            <p><strong>Statement:</strong> If thymic epithelial antigen expression programs (AIRE- and/or Fezf2-dependent TRAs) and/or peptide-supply pathways (TEC autophagy/endosomal processing) are reduced or spatially mislocalized relative to thymocyte migration into medullary APC zones, then negative selection will be incomplete for the underrepresented antigen classes, leading to selective export of autoreactive T cells and organ-specific autoimmunity toward those antigens.</p>
            <p><strong>Domain/Scope:</strong> Thymomas and thymus-like selection niches where thymopoiesis persists (mainly AB/B thymomas). Mechanistic components are primarily supported by thymus biology studies (mouse/human genetics) and thymoma-associated AIRE deficiency reports; thymoma-specific measurements for many components remain sparse.</p>
            <h4>Special Cases</h4>
            <ol>
                <li>Redundancy in chemokines and APC subsets can partially compensate for single-axis defects (e.g., CCR7/CCL21).</li>
                <li>AIRE loss does not predict all phenotypes; Fezf2 and non-TRA mechanisms may dominate for certain antigen classes.</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>AIRE in mTECs drives promiscuous gene expression and supports negative selection and Treg generation; thymomas often show deficient AIRE expression (reported in multiple reviews). <a href="../results/extraction-result-235.html#e235.0" class="evidence-link">[e235.0]</a> <a href="../results/extraction-result-212.html#e212.1" class="evidence-link">[e212.1]</a> <a href="../results/extraction-result-212.html#e212.0" class="evidence-link">[e212.0]</a> <a href="../results/extraction-result-211.html#e211.0" class="evidence-link">[e211.0]</a> </li>
    <li>Fezf2 controls an Aire-independent program of self-antigen expression in mTECs, implying that disruption of either program can create antigen-category gaps. <a href="../results/extraction-result-235.html#e235.1" class="evidence-link">[e235.1]</a> <a href="../results/extraction-result-212.html#e212.2" class="evidence-link">[e212.2]</a> </li>
    <li>Constitutive TEC autophagy supplies cytoplasmic peptides to MHC-II and is essential for tolerance in mouse models, providing a peptide-supply axis that could be perturbed in thymic epithelial tumors. <a href="../results/extraction-result-235.html#e235.4" class="evidence-link">[e235.4]</a> </li>
    <li>CCR7/CCL21-mediated cortex-to-medulla migration is essential for central tolerance; defects reduce exposure to medullary antigen presentation and impair deletion/Treg induction. <a href="../results/extraction-result-235.html#e235.6" class="evidence-link">[e235.6]</a> </li>
    <li>Thymomas show intratumoral immature thymocytes (TdT+/CD1a+) and abnormal thymopoiesis/architecture, consistent with potential migration/selection disorganization. <a href="../results/extraction-result-236.html#e236.2" class="evidence-link">[e236.2]</a> <a href="../results/extraction-result-205.html#e205.0" class="evidence-link">[e205.0]</a> <a href="../results/extraction-result-211.html#e211.1" class="evidence-link">[e211.1]</a> </li>
    <li>Aire-dependent thymic expression of Dsg3 and Aire−/− T cells can drive anti-Dsg3 IgG under experimental conditions, supporting the concept that missing intrathymic expression of a tissue antigen can permit later autoimmunity to that antigen class. <a href="../results/extraction-result-212.html#e212.1" class="evidence-link">[e212.1]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> <span style="color: green; font-weight: bold;">new</span></p>
        <p><strong>Explanation:</strong> It synthesizes known pathways into a new explanatory geometry (alignment/mismatch) with distinct predictions about which antigen classes escape and how histologic architecture drives specificity.</p>            <p><strong>What Already Exists:</strong> AIRE/Fezf2, autophagy, and chemokine-guided migration are known components of central tolerance; thymoma AIRE deficiency and thymopoiesis abnormalities are known themes.</p>            <p><strong>What is Novel:</strong> The explicit ‘antigen-flow mismatch’ construct: autoimmunity arises from spatial/trafficking misalignment between thymocyte movement and antigen/peptide availability, yielding predictable antigen-category ‘shadows’ rather than global tolerance failure.</p>
        <p><strong>References:</strong> <ul>
    <li>Anderson et al. (2018) Thymus machinery for T-cell selection [Aire/Fezf2/autophagy/chemokines—mechanistic ingredients]</li>
    <li>Takahashi/Wada (cited in 2019 PNP review) Aire-dependent Dsg3 tolerance [supports antigen-specific shadow concept]</li>
    <li>Strobel (2003) Pathomechanisms of Paraneoplastic MG [human thymoma selection output differences—architectural consequences]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
            <h3>Statement 1: Histotype dependence law (thymopoiesis-retaining tumors are higher risk)</h3>
            <p><strong>Statement:</strong> If a thymic epithelial tumor retains active thymopoiesis (abundant DP/immature thymocytes), then any central-tolerance misalignment (antigen-flow mismatch) will generate autoreactive export more efficiently than in tumors lacking thymopoiesis; therefore thymopoietic thymomas (AB/B1/B2/B3) have higher autoimmune association than thymic carcinomas.</p>
            <p><strong>Domain/Scope:</strong> Comparisons across thymic epithelial tumors by thymopoietic activity/histotype; supported by clinical associations and thymopoiesis observations rather than direct prospective mechanistic measurement.</p>
            <h4>Special Cases</h4>
            <ol>
                <li>Autoimmunity can still occur without robust thymopoiesis via peripheral mechanisms (molecular mimicry, cytokines, ectopic B-cell niches).</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Residual intratumoral thymopoiesis (ETPs, DP thymocytes) is reported mainly in AB/B thymomas; thymic carcinoma lacks DP thymocytes and cortical function in review summaries. <a href="../results/extraction-result-211.html#e211.1" class="evidence-link">[e211.1]</a> <a href="../results/extraction-result-211.html#e211.0" class="evidence-link">[e211.0]</a> </li>
    <li>Large clinical datasets show high PN/AI prevalence in thymoma and lower severe irAE rates in thymic carcinoma under ICIs; case report and reviews emphasize thymoma-specific susceptibility. <a href="../results/extraction-result-207.html#e207.0" class="evidence-link">[e207.0]</a> <a href="../results/extraction-result-211.html#e211.5" class="evidence-link">[e211.5]</a> <a href="../results/extraction-result-208.html#e208.0" class="evidence-link">[e208.0]</a> </li>
    <li>Immature thymocytes within thymoma tissue are directly observed by IHC (TdT+/CD1a+) in treated advanced thymoma cohort biopsies. <a href="../results/extraction-result-236.html#e236.2" class="evidence-link">[e236.2]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
        <p><strong>Explanation:</strong> Builds on known histotype differences but adds a mechanistic control parameter (thymopoiesis gain) tied to a novel mismatch framework.</p>            <p><strong>What Already Exists:</strong> Histotype dependence of thymopoiesis and clinical association of AB/B thymomas with autoimmunity are widely discussed.</p>            <p><strong>What is Novel:</strong> Linking histotype dependence specifically to a mechanistic ‘antigen-flow mismatch’ amplifier: thymopoiesis retention acts as a gain factor converting architectural/molecular mismatches into systemic autoreactive export.</p>
        <p><strong>References:</strong> <ul>
    <li>Autoimmunity in thymic epithelial tumors review (2024) [histotype associations and thymopoiesis retention]</li>
    <li>Rajan (2019) Avelumab in advanced thymoma [immature thymocytes; high irAEs]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
        </div>
        <div class="section">
            <h2>Theory (Additional Details)</h2>
                        <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Spatial transcriptomics/proteomics of thymomas will show spatial segregation (mismatch) between (i) TRA-expressing epithelial cells (AIRE/Fezf2 modules), (ii) MHC-II peptide-loading machinery (autophagy/TSSP markers), and (iii) thymocyte developmental streams, and the degree of segregation will correlate with autoimmune phenotype burden.</li>
                <li>Autoimmune phenotype ‘category’ will map to which antigen program is more impaired: AIRE-low tumors will preferentially associate with AIRE-target antigen autoimmunity, whereas Fezf2-low tumors will associate with a distinct antigen set (predictable from Fezf2 target repertoire).</li>
                <li>Markers of impaired medullary entry (CCR7/CCL21 axis disruption surrogates) will correlate with higher autoreactive export signatures and higher frequency of multi-organ autoimmunity.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Engineering organoid co-cultures of patient-derived thymoma epithelium + thymocytes will reproduce antigen-shadow gaps measurable by peptide-MHC display and negative-selection assays, and these gaps will predict patient-specific autoantibody targets (e.g., AChR vs desmogleins vs erythroid antigens).</li>
                <li>Restoring only trafficking cues (e.g., exogenous CCL21 gradients) in such organoid systems will partially rescue negative selection even if AIRE remains low, demonstrating that alignment can compensate for reduced antigen breadth.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>If spatial profiling shows that TRA expression, peptide-supply machinery, and thymocyte positioning are well-aligned in thymomas regardless of autoimmune phenotype, the core mismatch claim is undermined.</li>
                <li>If Fezf2/AIRE and autophagy/TSSP signatures do not correlate at all with the category of autoantibodies/autoimmune syndromes across patients, the predicted antigen-category mapping fails.</li>
                <li>If thymic carcinoma samples with minimal thymopoiesis nonetheless show the same degree of mismatch and similar autoimmune rates, thymopoiesis retention as an amplifier is questioned.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>Strong peripheral B-cell–driven phenomena (peritumoral germinal centers, chemokine-driven B-cell recruitment in micronodular thymoma) can generate autoantibodies even if central mismatch is modest; this theory treats them as downstream rather than primary. <a href="../results/extraction-result-211.html#e211.3" class="evidence-link">[e211.3]</a> <a href="../results/extraction-result-209.html#e209.1" class="evidence-link">[e209.1]</a> </li>
</ol>        </div>        <div style="height: 30px;"></div>
    </div>
</body>
</html>